loading page

Extracorporeal membrane oxygenator as a bridge to definitive treatment in patients with persistent infective endocarditis
  • +1
  • Soraya Fereydooni,
  • Kevin Hu,
  • Michal Shang,
  • Prashanth Vallabhajosyula
Soraya Fereydooni
Yale University School of Medicine Yale Center for Thoracic Aortic Disease

Corresponding Author:[email protected]

Author Profile
Kevin Hu
Yale University School of Medicine Yale Center for Thoracic Aortic Disease
Author Profile
Michal Shang
Yale University School of Medicine Yale Center for Thoracic Aortic Disease
Author Profile
Prashanth Vallabhajosyula
Yale University School of Medicine Yale Center for Thoracic Aortic Disease
Author Profile

Abstract

Considering the worsening opioid epidemic, complicated infective endocarditis (IE) secondary to intravenous drug use (IVDU) that fails medical management is increasingly common. We present a 31-year-old patient post tricuspid valve replacement who relapsed with recurrent IE and secondary complications of severe tricuspid stenosis and regurgitation, ventricular septal defect (VSD), pulmonary emboli, right-sided heart failure with severe hepatic congestion, and cardiogenic shock. Despite maximal medical management, the patient remained in septic and cardiogenic shock with a potential disposition to hospice care. Upon consulting cardiothoracic surgery, she underwent a first-stage valvectomy with Extracorporeal Membrane Oxygenation (ECMO) as a bridge to definitive treatment. After clearance of infection, she underwent a second-stage valve replacement, VSD repair, and final ECMO decannulation. Our case alludes to ECMO as a potential bridge for patients with complicated infective endocarditis who fail medical management and are high-risk candidates for immediate definitive surgical management.